Inflammatory factor tumor necrosis factor-alpha (TNF-alpha) activates P-glycoprotein (P-gp) by phosphorylating c-Jun and thus promotes transportation in placental cells

Background: P-glycoprotein (P-gp), encoded by the ABCB1 gene, actively pumps drugs and other xenobiotics from trophoblast cells back into the maternal circulation and thus acts as one of the most critical protectors of the fetus. The effect of tumor necrosis factor-alpha (TNF-alpha) on P-gp and molecule-transporting activity remains unknown. The goal of this study was to investigate the role of TNF-alpha in placental molecule -transporting activity and the underlies mechanisms. Methods: Cultured human placental choriocarcinoma cell lines, Bewo, JEG-3 and JAR, were used in this study. Cultured cells were incubated with 5, 10 and 20 ng/mL of recombinant TNF-alpha (rTNF-alpha) for 24 h, respectively, for follow-up experiments. The dimer form and expression of activator protein-1 (AP-1) family members were detected using Western blot (WB) and chromatin immunoprecipitation (ChIP). mRNA and protein expression of ABCB1 were detected using reverse transcriptional quantitative polymerase chain reaction (RT-qPCR) and WB, respectively. Double luciferase labeling was used to verify the concentration of digoxin. Electromobility shift assay (EMSA) and ChIP were used to identify the binding ability of c-Jun to ABCB1 gene promoter. Proliferation and apoptosis of Bewo cells were determined using flow cytometry. Digoxin concentration were determined using dual luciferase labeling method. Results: Administration of rTNF-alpha upregulated the expression of c-Jun but not JunB or JunD in a dose -dependent manner and promoted the binding of c-Jun to the ABCB1 promoter region in Bewo cells. rTNF-alpha also increased the uptake of two P-gp-specific substrates, Rh123 and DiOC2(3), a function reversed by the addition of SP600125 and SR11302. We also found that rTNF-alpha increased the efflux ratio of digoxin, an outcome that was reversed, as expected, by inhibiting c-Jun and P-gp binding activities. Furthermore, we identified that rTNF-alpha tightly regulates the molecule-transporting activity of P-gp by promoting the phosphorylation of c-Jun. Conclusions: TNF-alpha activates P-gp to promote placental molecule-transporting activity by directly upregulating c-Jun expression and phosphorylation. These findings demonstrate the clinical significance of TNF-alpha in modulating the placental barrier, which plays an important role in protecting fetus against harmful drugs.

Automated summary

The study demonstrates that TNF-alpha activates P-gp to promote placental molecule-transporting activity by directly upregulating c-Jun expression and phosphorylation, which plays a crucial role in protecting the fetus against harmful drugs.